Litcius/Paper detail

Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable

Ajay K. Nooka, Luciano J. Costa, CJ Gasparetto, PG Richardson, DS Siegel, Ajai Chari, Suzanne Lentzsch, Sundar Jagannath, Joseph Mıkhael

2022Clinical Lymphoma Myeloma & Leukemia20 citationsDOI

Topics & Concepts

MedicineDosingDexamethasoneMultiple myelomaBortezomibDaratumumabPharmacologyCancer researchInternal medicineMultiple Myeloma Research and TreatmentsPeptidase Inhibition and AnalysisProtein Degradation and Inhibitors
Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable | Litcius